Waters Corporation $WAT Position Reduced by Mawer Investment Management Ltd.

Mawer Investment Management Ltd. decreased its holdings in Waters Corporation (NYSE:WAT) by 7.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 476,561 shares of the medical instruments supplier’s stock after selling 36,953 shares during the quarter. Mawer Investment Management Ltd. owned 0.80% of Waters worth $166,339,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC increased its position in shares of Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after acquiring an additional 673 shares in the last quarter. Alps Advisors Inc. purchased a new stake in Waters in the 1st quarter worth approximately $350,000. Cerity Partners LLC boosted its stake in shares of Waters by 134.0% during the 1st quarter. Cerity Partners LLC now owns 13,951 shares of the medical instruments supplier’s stock valued at $5,142,000 after buying an additional 7,989 shares during the period. Xponance Inc. grew its holdings in shares of Waters by 0.4% during the 1st quarter. Xponance Inc. now owns 11,652 shares of the medical instruments supplier’s stock valued at $4,295,000 after acquiring an additional 51 shares in the last quarter. Finally, CWM LLC raised its holdings in shares of Waters by 42.8% during the first quarter. CWM LLC now owns 2,031 shares of the medical instruments supplier’s stock worth $749,000 after acquiring an additional 609 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Price Performance

Shares of NYSE:WAT opened at $377.23 on Tuesday. The company has a market cap of $22.46 billion, a price-to-earnings ratio of 34.01, a PEG ratio of 3.19 and a beta of 1.11. The business has a 50 day moving average price of $325.04 and a 200 day moving average price of $326.28. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56.

Waters (NYSE:WAT) last issued its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $608.55 million during the quarter. Research analysts predict that Waters Corporation will post 12.86 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Redburn Partners set a $390.00 price target on Waters in a research note on Wednesday, October 8th. Cowen reaffirmed a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Wells Fargo & Company boosted their target price on shares of Waters from $315.00 to $385.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Waters and gave the company a “hold” rating in a research note on Tuesday, August 5th. Finally, UBS Group restated a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $381.57.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.